ATRX and prostate cancer: Many chromatin remodelers have been correlated with ploidy maintenance [46] and, among them, RAD54 in particular is found over-expressed up to 5-fold in prostatic cancer cells characterized by recurrent non-reciprocal translocations [21], [47].